Published trade mark details for 2259832
This information was published on 2025-02-24T08:17:57 for IP Right Registration Published.
| Field | Value |
| (210) | 2259832 (IR 1653431) |
| (220) |
26 Jan 2022
|
| (300) |
US, 16 Aug 2021, 90884754
|
| (500) | |
| (511) (510) |
Class 5
Pharmaceutical preparations for human use; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia. Class 42 Research and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions. Class 44 Providing medical information; providing medical information in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of psychiatric, neurological, central nervous system, hormonal, genetic and movement diseases, disorders and conditions. |
| (540) |
|
| (550) | Figurative |
| (730) |
Neurocrine Biosciences, Inc.
|
| (750) |
King & Wood Mallesons
|
Find out more about publications on the About page.